Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.89 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.89 |
| ▸ | ENPEP | Q07075 | 6/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.45 |
| ▸ | APEX1 | P27695 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | NOS2 | P35228 | 1/20 | 0.45 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.44 |
| ▸ | GSR | P00390 | 2/20 | 0.44 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.44 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.44 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.44 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cysteine SCHEMBL5218619 | 1.00 | PTGS1 (0.89) | PTGS1SLC7A11ENPEPALOX15BLM | |
| Cysteine SCHEMBL25292211 | 0.94 | PTGS1 (0.89) | PTGS1SLC7A11ENPEPALOX15BLM | |
| Cysteine SCHEMBL7270341 | 0.94 | PTGS1 (0.89) | PTGS1SLC7A11ENPEPALOX15BLM | |
| Cysteine SCHEMBL11344868 | 0.94 | PTGS1 (0.89) | PTGS1SLC7A11ENPEPALOX15BLM | |
| Cysteine SCHEMBL4289403 | 0.94 | — | — | |
| Cysteine SCHEMBL5705430 | 0.94 | PTGS1 (1.00) | PTGS1SLC7A11ENPEPALOX15BLM | |
| Cysteine SCHEMBL7898895 | 0.94 | PTGS1 (1.00) | PTGS1SLC7A11ENPEPALOX15BLM | |
| Cysteine SCHEMBL21110883 | 0.94 | PTGS1 (1.00) | PTGS1SLC7A11ENPEPALOX15BLM | |
| Cysteine SCHEMBL339562 | 0.94 | PTGS1 (1.00) | PTGS1SLC7A11ENPEPALOX15BLM | |
| Cysteine SCHEMBL1868335 | 0.94 | PTGS1 (1.00) | PTGS1SLC7A11ENPEPALOX15BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1575900-A4 | N-METHYL AMINO ACIDS | UBIQUITOUS TECHNOLOGIES PTY LT (AU) | 2007-02-21 | — | — | EP | disclosed |
| US-20050245432-A1 | N-methyl amino acids | UBIQUITOUS TECHNOLOGIES PTY. LTD. (AU) | 2005-11-03 | — | — | US | disclosed |
| EP-1575900-A1 | N-METHYL AMINO ACIDS | UBIQUITOUS TECHNOLOGIES PTY LTD (AU) | 2005-09-21 | — | — | EP | disclosed |
| WO-2004007427-A1 | N-METHYL AMINO ACIDS | UBIQUITOUS TECHNOLOGIES PTY LTD (AU) | 2004-01-22 | — | — | WO | disclosed |
| WO-2003031376-A1 | SOLID PHASE SYNTHESIS OF SUBSTITUTED 1,5-BENZODIAZEPINE-2-ONE AND 1,5-BENZOTHIAZEPINE-2-ONE | AVENTIS PHARMACEUTICALS INC. (US) | 2003-04-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050245432-A1 | N-methyl amino acids | VIP, NPPA, PTMS | PTGS1 1827/4885SLC7A11 79/4885ENPEP 30/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.